Contemporary Diagnosis and Management of Rheumatic Heart Disease: Implications for Closing the Gap, a Scientific Statement from the American Heart Association

Raman Krishna Kumar, MD, DM, Manuel J. Antunes, MD, PhD, DSc Andrea Beaton, MD, FAHA, Mariana Mirabel, MD, PhD, Vuyisile T. Nkomo, MD, MPH Emmy Okello, MBChB, MMed, PhD Prakash Raj Regmi, MD Boglarka Reményi, MBBS, FRACP, PhD Karen Sliwa-Hähnle, MD, PhD, Liesl Joanna Zühlke, MB, CHB, DCH, FCPaeds, Cert Card MPH, MSc, PhD, and Craig Sable, MD

Circulation. 2020;142:e337–e357.

Previous
Previous

The American Heart Association’s Call to Action for Reducing the Global Burden of Rheumatic Heart Disease: A Policy Statement from the American Heart Association

Next
Next

The personal and clinical impact of screen-detected maternal rheumatic heart disease in Uganda: a prospective follow up study